医療用途向けスマート応答性組織接着剤の最近の進歩
Shiqi Lin1,2, Qiang Jin1, Ji Wang1
1Center for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Frontiers in medicine
|December 15, 2025
まとめ
スマート応答性バイオ接着剤は、組織修復のために調整可能な接着とオンデマンドの剥離を提供する。このレビューは、その設計、メカニズム、およびアプリケーションを分析し、将来の臨床翻訳を導く。
科学分野:
- 生体材料科学
- 組織工学
- 医療用接着剤
背景:
- 従来の縫合糸は、時間のかかる手順や二次的な組織損傷などの制限を示している。
- 既存のバイオ接着剤は、接着強度と分解速度に関する正確な制御を欠いていることが多い。
- スマート応答性バイオ接着剤は、調整可能な特性とオンデマンドの剥離を提供し、これらの制限に対処する。
研究 の 目的:
- スマート応答性バイオ接着剤の体系的なレビューを提供すること。
- 過去10年間の設計戦略、動作原理、および生物医学的応用を分析すること。
- 現在の制限と臨床翻訳の将来の方向性を議論すること。
主な方法:
- スマート応答性接着剤に焦点を当てた包括的な文献レビュー。
- 合成戦略と接着メカニズムの分析。
- 生物医学的応用と将来の展望の評価。
主要な成果:
- スマート応答性バイオ接着剤は、調整可能な接着とオンデマンドの剥離能力を示す。
- これらの材料は、組織修復、薬物送達、およびバイオエレクトロニクスインターフェイスを含む多様なアプリケーションで可能性を示す。
- 設計戦略と動作原理の包括的な分析が実施された。
結論:
- スマート応答性バイオ接着剤は、従来のメソッドに対する大きな進歩を表す。
- 実験室から臨床実践への移行を加速するためには、さらなる研究開発が必要である。
- このレビューは、高度な組織接着剤を開発する研究者に貴重な洞察を提供する。
さらに関連する動画
関連する概念動画
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


